Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:20AM AEST - The Australian Stockmarket opens in 40 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
GTX Inc. (GTXI)
8:00AM AEST:
4.16 USD
0.04 (0.97%)
MORE ON GTXI
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
GTx, Inc.
(NGM:GTXI) Delayed quote data
Last Trade:
4.16 USD
Trade Time:
8:00AM AEST
Change:
0.04 (0.97%)
Prev Close:
4.12
Open:
4.15
Bid:
4.05
x 500
Ask:
4.18
x 200
1y Target Est:
4.00
Day's Range:
4.12 - 4.21
52wk Range:
3.22 - 13.59
Volume:
76,807
Avg Vol
(3m)
:
383,960
Market Cap:
151.51M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-1.35
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add GTXI to Portfolio
Download Data
HEADLINES
This Week's Failed Trials, Missed Targets in Biotech
at Seeking Alpha
(Sun, Dec 20)
Movers roundup: Waste Services, GTx
AP
(Tue, Dec 15)
GTx shares fall after delay leads to job cuts
AP
(Tue, Dec 15)
GTx Announces Reduction in Force
Business Wire
(Sat, Dec 12)
GTX INC /DE/ Financials
EDGAR Online Financials
(Sat, Nov 14)
GTx, Inc. Earnings Call scheduled for 9:00 am ET today
CCBN
(Tue, Nov 10)
GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online
(Tue, Nov 10)
3 Stocks Attracting Top Investors
at Motley Fool
(Thu, Nov 5)
Hemispherx Cops to Ampligen FDA Delay
at TheStreet.com
(Tue, Nov 3)
GTx shares crater on FDA rejection
at MarketWatch
(Tue, Nov 3)
YRC Worldwide, LDK Solar: Midday Volume Plays
at TheStreet.com
(Tue, Nov 3)
More Headlines for GTXI...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.33
EPS Est (in 2 years)
(Dec-10)
:
-0.88
Avg Rec (current)*:
3.3
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices